Senseonics Holdings, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 10, 2023 at 4:30 p.m. Eastern Time
27 Juillet 2023 - 10:05PM
Business Wire
Senseonics Holdings, Inc. (NYSE-American: SENS), a medical
technology company focused on the development and manufacturing of
long-term, implantable continuous glucose monitoring (CGM) systems
for people with diabetes, today announced that it plans to release
its second quarter 2023 financial results after market close on
Thursday, August 10, 2023.
Management will hold a conference call to review the Company’s
second quarter 2023 performance starting at 4:30 p.m. (Eastern
Time) on the same day. The conference call will be concurrently
webcast. The link to the webcast will be available on Senseonics
Holdings, Inc. website at www.senseonics.com by navigating to
“Investor Relations,” and then “Events & Publications,” and
will be archived there for future reference. To listen to the
conference call, please dial 1-888-317-6003 (US/Canada) or
1-412-317-6061 (International), passcode 2402364, approximately ten
to five minutes prior to start time.
About Senseonics
Senseonics Holdings, Inc. (“Senseonics”) is a medical technology
company focused on the development and manufacturing of glucose
monitoring products designed to transform lives in the global
diabetes community with differentiated, long-term implantable
glucose management technology. Senseonics' CGM systems, Eversense®,
Eversense® XL and Eversense® E3 include a small sensor inserted
completely under the skin that communicates with a smart
transmitter worn over the sensor. The glucose data are
automatically sent every 5 minutes to a mobile app on the user's
smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230727213186/en/
INVESTOR CONTACT Philip Taylor Gilmartin Group
415-937-5406 investors@senseonics.com
Senseonics (AMEX:SENS)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Senseonics (AMEX:SENS)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024